These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7498302)

  • 21. Selective 5-HT1A antagonists WAY 100635 and NAD-299 attenuate the impairment of passive avoidance caused by scopolamine in the rat.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2003 Feb; 28(2):253-64. PubMed ID: 12589378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spatial memory deficits following stimulation of hippocampal 5-HT1B receptors in the rat.
    Buhot MC; Patra SK; Naïli S
    Eur J Pharmacol; 1995 Oct; 285(3):221-8. PubMed ID: 8575507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine blockade of MK-801-induced learning/memory impairment in the mEPM: Role of 5-HT
    López Hill X; Richeri A; Scorza MC
    Physiol Behav; 2017 Oct; 179():346-352. PubMed ID: 28705535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of dorsal hippocampal alpha-adrenergic receptors in the effect of scopolamine on memory retrieval in inhibitory avoidance task.
    Azami NS; Piri M; Oryan S; Jahanshahi M; Babapour V; Zarrindast MR
    Neurobiol Learn Mem; 2010 May; 93(4):455-62. PubMed ID: 20064624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the selective 5-HT1A receptor antagonist WAY 100635 on the inhibition of e.p.s.ps produced by 5-HT in the CA1 region of rat hippocampal slices.
    Pugliese AM; Passani MB; Corradetti R
    Br J Pharmacol; 1998 May; 124(1):93-100. PubMed ID: 9630348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of the dorsal hippocampal dopamine D1 receptors inhibits the scopolamine-induced state-dependent learning in rats.
    Piri M; Rostampour M; Nasehi M; Zarrindast MR
    Neuroscience; 2013 Nov; 252():460-7. PubMed ID: 23933216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of mechanisms mediating 8-OH-DPAT-induced impairment of spatial memory: involvement of 5-HT1A receptors in the dorsal hippocampus in rats.
    Egashira N; Yano A; Ishigami N; Mishima K; Iwasaki K; Fujioka M; Matsushita M; Nishimura R; Fujiwara M
    Brain Res; 2006 Jan; 1069(1):54-62. PubMed ID: 16386718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ex vivo study of 5-HT(1A) and 5-HT(7) receptor agonists and antagonists on cAMP accumulation during memory formation and amnesia.
    Perez-García G; Meneses A
    Behav Brain Res; 2008 Dec; 195(1):139-46. PubMed ID: 18723050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chlordiazepoxide interactions with scopolamine and dizocilpine: novel cooperative and antagonistic effects on spatial learning.
    Padlubnaya D; Galizio M; Pitts RC; Keith JR
    Behav Neurosci; 2005 Oct; 119(5):1331-8. PubMed ID: 16300439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190.
    Routledge C; Gurling J; Ashworth-Preece MA; Dourish CT
    Eur J Pharmacol; 1995 Apr; 276(3):281-4. PubMed ID: 7601215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strain-dependent effects on acquisition and reversal of visual and spatial tasks in a rat touchscreen battery of cognition.
    Kumar G; Talpos J; Steckler T
    Physiol Behav; 2015 May; 144():26-36. PubMed ID: 25744936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posttraining intrahippocampal estradiol injections enhance spatial memory in male rats: interaction with cholinergic systems.
    Packard MG; Kohlmaier JR; Alexander GM
    Behav Neurosci; 1996 Jun; 110(3):626-32. PubMed ID: 8889009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of intrahippocampal injections of N-methyl-D-aspartate receptor antagonists and scopolamine on working and reference memory assessed in rats by a three-panel runway task.
    Ohno M; Yamamoto T; Watanabe S
    J Pharmacol Exp Ther; 1992 Dec; 263(3):943-50. PubMed ID: 1361577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties.
    Schechter LE; Smith DL; Rosenzweig-Lipson S; Sukoff SJ; Dawson LA; Marquis K; Jones D; Piesla M; Andree T; Nawoschik S; Harder JA; Womack MD; Buccafusco J; Terry AV; Hoebel B; Rada P; Kelly M; Abou-Gharbia M; Barrett JE; Childers W
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1274-89. PubMed ID: 15951399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB; Koek W
    Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the novel 5-HT(6) receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating.
    Schreiber R; Vivian J; Hedley L; Szczepanski K; Secchi RL; Zuzow M; van Laarhoven S; Moreau JL; Martin JR; Sik A; Blokland A
    Eur Neuropsychopharmacol; 2007 Mar; 17(4):277-88. PubMed ID: 16989988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ondansetron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset.
    Carey GJ; Costall B; Domeney AM; Gerrard PA; Jones DN; Naylor RJ; Tyers MB
    Pharmacol Biochem Behav; 1992 May; 42(1):75-83. PubMed ID: 1388279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of intrahippocampal injections of ritanserin (5HT2A/2C antagonist) and granisetron (5HT3 antagonist) on learning as assessed in the spatial version of the water maze.
    Naghdi N; Harooni HE
    Behav Brain Res; 2005 Feb; 157(2):205-10. PubMed ID: 15639171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135.
    Fornal CA; Metzler CW; Gallegos RA; Veasey SC; McCreary AC; Jacobs BL
    J Pharmacol Exp Ther; 1996 Aug; 278(2):752-62. PubMed ID: 8768728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro.
    Corradetti R; Le Poul E; Laaris N; Hamon M; Lanfumey L
    J Pharmacol Exp Ther; 1996 Aug; 278(2):679-88. PubMed ID: 8768719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.